Testing effectiveness (Phase 2)Study completedNCT00006097What this trial is testingChemotherapy in Treating Patients With Chronic Lymphocytic LeukemiaWho this might be right forLeukemia Boston Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT07218510What this trial is testingVenetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity TrialWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT04172246What this trial is testingStudy of Zanubrutinib in Japanese Participants With B-Cell MalignanciesWho this might be right forMature B-cell Malignancies BeiGene 55
Large-scale testing (Phase 3)Study completedNCT02049515What this trial is testingExtension Study of Duvelisib and Ofatumumab in Participants With CLL/SLL Previously Enrolled in Study IPI-145-07Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma SecuraBio 99
Early research (Phase 1)Study completedNCT01593696What this trial is testingAnti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or LymphomaWho this might be right forALLB Cell LymphomaLeukemia+2 more National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Study completedNCT00683046What this trial is testingT-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic MalignanciesWho this might be right forAcute Myelogenous LeukemiaLymphoid LeukemiaChronic Myelogenous Leukemia+6 more University of Chicago 204
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115What this trial is testingDonor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more City of Hope Medical Center 260
Testing effectiveness (Phase 2)Ended earlyNCT00360776What this trial is testingTipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte LeukemiaWho this might be right forStage III Chronic Lymphocytic LeukemiaStage IV Chronic Lymphocytic LeukemiaT-cell Large Granular Lymphocyte Leukemia National Cancer Institute (NCI) 25
Not applicableUnknownNCT03633045What this trial is testingObservational Study of Ibrutinib Use in CLLWho this might be right forChronic Lymphocytic Leukemia Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT03961672What this trial is testingIntermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia+1 more City of Hope Medical Center 15
Very early researchLooking for participantsNCT06890494What this trial is testingClinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell LeukemiaWho this might be right forLeukemia Beijing GoBroad Hospital 3
Not applicableStudy completedNCT02582879What this trial is testingInformCLL™: A Disease Registry for Patients With Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia (CLL) Pharmacyclics LLC. 1,504
Testing effectiveness (Phase 2)Study completedNCT00562770What this trial is testingOral Valganciclovir Versus ValacyclovirWho this might be right forChronic Lymphocytic LeukemiaLeukemia M.D. Anderson Cancer Center 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT04505254What this trial is testingAcalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00438854What this trial is testingDasatinib in Relapsed Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Massachusetts General Hospital 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07796373What this trial is testingNemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inhibitor or Pirtobrutinib and Previously Treated With a BCL2 InhibitorWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia National Heart, Lung, and Blood Institute (NHLBI) 32
Early research (Phase 1)UnknownNCT03599375What this trial is testingImmunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic LeukemiaWho this might be right forLeukemia, B-Cell jiuwei cui 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03467867What this trial is testingVenetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLLWho this might be right forChronic Lymphocytic Leukemia Georgetown University 25
Testing effectiveness (Phase 2)Study completedNCT01626495What this trial is testingPhase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and LymphomaWho this might be right forB Cell LeukemiaB Cell Lymphoma University of Pennsylvania 73
Early research (Phase 1)Study completedNCT00330252What this trial is testingWeekly Subcutaneous Alemtuzumab and Rituximab for Relapsed CLLWho this might be right forChronic Lymphocytic Leukemia Dana-Farber Cancer Institute 29